Effects of bupropion, alone or coadministered with nicotine, on social behavior in mice

Addiction Biology

Volumn 13, Issue 3-4, 2008, Pages 301-309

  Gómez, Carmen ^a   Carrasco, Carmen ^a   Redolat, Rosa ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Aggression; Anxiety; Bupropion; Mice; Nicotine; Social interaction

Indexed keywords

AMFEBUTAMONE; NICOTINE TARTRATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL INTERACTION; STATISTICAL SIGNIFICANCE;

AGGRESSION; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; GANGLIONIC STIMULANTS; MALE; MICE; NICOTINE; SOCIAL BEHAVIOR; TOBACCO USE DISORDER;

EID: 49349118108     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2008.00099.x     Document Type: Article

References (71)

1. Acri JB, Grunberg NB (1992) A psychophysical task to quantify smoking cessation-induced irritability: the reactive irritability scale (RIS). Addict Behav 17 : 587 601.
2. Ascher JA, Cole JO, Colin JN, Feighner JP, Ferris RM, Fibiger HC, Golden RN, Martin P, Potter WZ, Richelson E, Sulser F (1995) Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 56 : 395 401.
3. Blanchard RJ, Wall PM, Blanchard DC (2003) Problems in the study of rodent aggression. Horm Behav 44 : 161 170.
4. Bondarev ML, Bondareva TS, Young R, Glennon RA (2003) Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol 474 : 85 93.
5. Brain PF, Benton D, Childs S, Parmigiani S (1981) The effect of the opponent in tests of murine aggression. Behav Processes 6 : 319 328.
6. Brain PF, Kusumorini N, Benton D (1991) 'Anxiety' in laboratory rodents: a brief review of some recent behavioural developments. Behav Processes 25 : 71 80.
7. Brain PF, McAllister KH, Walmsley SV (1989) Drug effects on social behaviour methods in ethopharmacology. In : Boulton AA, Baker GB, Greenshaw AJ, eds. Neuromethods, Volume 13 Psychopharmacology, pp. 687 739. Clifton, NJ : The Humana Press Inc.
8. Brioni JD, O'Neill AB, Kim DJ, Decker MW (1993) Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur J Pharmacol 6 : 1 8.
9. Brody AL, Mandelkern MA, Lee G, Smith E, Sadeghi M, Saxena S, Jarvik ME, London ED (2004) Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study. Psychiatry Res Neuroimaging 130 : 269 281.
10. Carrasco MC, Vicens P, Vidal J, Redolat R (2004) Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice. Prog Neuropsychopharmacol Biol Psychiatry 28 : 1135 1141.
11. Carrasco MC, Vicens P, Vidal J, Redolat R (2006) Effects of co-administration of bupropion and nicotinic agonists on the elevated plus-maze test in mice. Prog Neuropsychopharmacol Biol Psychiatry 30 : 455 462.
12. Cherek DR (1981) Effects of smoking different doses of nicotine on human aggressive behavior. Psychopharmacol 75 : 339 345.
13. Cherek DR, Bennett RH, Grabowski J (1991) Human aggressive responding during acute tobacco abstinence: effects of nicotine and placebo gum. Psychopharmacol 104 : 317 322.
14. Cooper BR, Hester TJ, Maxwel RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215 : 127 134.
15. Costall B, Kelly ME, Naylor RJ, Onaivi ES (1989) The actions of nicotine and cocaine in a mouse model of anxiety. Pharmacol Biochem Behav 33 : 197 203.
16. Cryan JF, Bruijnzeel AW, Skjei KL, Markou A (2003a) Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacol 168 : 374 358.
17. Cryan JF, Gasparini F, Van Heeke G, Markou A (2003b) Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion. Drug Discov Today 22 : 1025 1034.
18. Cutler MG (1994) Anxiolytic drugs: does ethopharmacological analysis indicate commonalties in their mode of action? In : Cooper SJ, Hendrie CA, eds. Ethol Psychopharmacol, pp. 45 58. Chichester : John Wiley and Sons.
19. Damaj MI, Carroll FI, Eaton JB, Navarro HA, Blough BE, Mirza S, Lucas RJ, Martin BR (2004) Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors. Mol Pharmacol 66 : 675 682.
20. Damaj MI, Slemmer J, Carroll FI, Martin BR (1999) Pharmacological characterization of nicotine's interaction with cocaine and cocaine analogs. J Pharmacol Exp Ther 289 : 1229 1236.
21. De Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463 : 145 161.
22. Dhir A, Kulkarni SK (2007) Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol 568 : 177 185.
23. DiFranza JR, Wellman RJ (2007) Sensitization to nicotine: how the animal literature might inform future human research. Nicotine Tob Res 9 : 9 20.
24. Durcan MJ, Deener G, White JD (2000) Factors associated with relapse: lessons from a bupropion SR relapse prevention trial. In : Proceedings of the Sixth Annual Conference of the Society on Nicotine and Tobacco, Research, February, pp. 18 20. Arlington, VA, USA.
25. Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT (2006) Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev 12 : 178 207.
26. Espert R, Navarro JF, Salvador A, Simon VM (1993) Effects of morphine hydrochloride on social encounters between male mice. Agress Behav 19 : 377 383.
27. Estelles J, Rodríguez-Arias M, Aguilar MA, Miñarro J (2004) Social behavioural profile of cocaine in isolated and grouped male mice. Drug Alcohol Depend 76 : 115 123.
28. Ferris RM, Cooper BR, Maxwell RA (1983) Studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry 44 : 74 78.
29. Foley KF, DeSanty KP, Kast RE (2006) Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother 6 : 1249 1265.
30. Fryer JD, Lukas RJ (1999) Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. J Pharmacol Exp Ther 288 : 88 92.
31. Hughes JR, Stead LF, Lancaster T (2007) Antidepressants for smoking cessation. Cochrane Database Syst Rev 24 : CD000031.
32. Johnson SK, Carlson KM, Lee J, Burr LE, Wagner CE (2003) Effects of nicotine on target biting and resident-intruder attack. Life Sci 73 : 311 317.
33. Jorenby DE, Hatsukami DK, Smith SS, Fiore MC, Allen S, Jensen J, Baker TB (1996) Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain. Psychopharmacol 128 : 130 138.
34. Jorenby DE, Leischow SJ, Nides MA, Rennard SI, Johnston JA, Hughes AR, Smith SS, Muramoto JL, Daughton DM, Doan K, Fiore MC, Baker TB (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340 : 685 691.
35. Kalueff AV, Lou Y-R, Laaksi I, Tuohimaa P (2004) Increased grooming behavior in mice lacking vitamin D receptors. Physiol Behav 82 : 405 409.
36. Kalueff AV, Tuohimaa P (2004a) Grooming analysis algorithm for neurobehavioural stress research. Brain Res Protoc 13 : 151 158.
37. Kalueff AV, Tuohimaa P (2004b) Contrasting grooming phenotypes in three mouse strains markedly different in anxiety and activity (129S1, BALB/c and NMRI). Behav Brain Res 160 : 1 10.
38. Lerman C, Niaura R, Collins BN, C, Wileyto P, Audrain-McGovern J, Hawk L, Epstein LH (2004) Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 18 : 362 366.
39. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacol 138 : 217 230.
40. Malin DH, Lake JR, Smith TD, Khambati HN, Meyers-Paal RL, Montellano AL, Jennings RE, Erwin DS, Presley SS, Perales BA (2006) Bupropion attenuates nicotine abstinence syndrome in the rat. Psychopharmacol 184 : 494 503.
41. Mansvelder HD, Fagen ZM, Chang B, Mitchum R, McGehee DS (2007) Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area. Biochem Pharmacol 74 : 1283 1291.
42. Martinez M, Castaño D, Simon V, Brain PF (1986) An ethopharmacological assessment of the influences of ciproterone acetate in social interactions in male mice. ICRS Med Sci 14 : 44 45.
43. Masuda Y, Ishigooka S, Matsuda Y (2000) Digging behavior of ddY mouse. Exp Anim 49 : 235 237.
44. Miczek KA, Fish EW, de Bold JF, Almeida RMM (2002) Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid systems. Psychopharmacol 163 : 434 458.
45. Navarro JF, Maldonado E (2002) Acute and subchronic effects of MDMA ('ecstasy') on anxiety in male mice tested in the elevated plus-maze. Prog Neuropsychopharmacol Biol Psychiatry 26 : 1151 1154.
46. Navarro JF, Rivera A, Maldonado E, Cavas M, de la Calle A (2004) Anxiogenic-like activity of 3,4-methylenedioxy-metamphetamine ('Ecstasy') in the social interaction test is accompanied by an increase of c-fos expression in mice amygdale. Prog Neuropsychopharmacol Biol Psychiatry 28 : 249 254.
47. Nelson RJ, Trainor BC (2007) Neural mechanisms of aggression. Nat Rev Neurosci 8 : 536 546.
48. Parmigiani S, Ferrari PF, Palanza P (1998) An evolutionary approach to behavioral pharmacology: using drugs to understand proximate and ultimate mechanisms of different forms of agresión in mice. Neurosci Biobehav Rev 23 : 143 153.
49. Parrott DJ, Zeichner A (2001) Effects of nicotine deprivation and irritability on physical aggression in male smokers. Psychol Addict Behav 15 : 133 139.
50. Paterson NE, Balfour DJ, Markou A (2007) Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 25 : 3099 3108.
51. Portugal GS, Gould TJ (2007) Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol Biochem Behav 88 : 179 187.
52. Rauhut AS, Neugebauer N, Dowskin LP, Bardo MT (2003) Effect of bupropion on nicotine self-administration in rats. Psychopharmacol 169 : 1 9.
53. Redolat R, Brain PF, Simon VM (1991) Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity. Neuropharmacol 30 : 41 46.
54. Redolat R, Gómez MC, Vicens P, Carrasco MC (2005a) Bupropion effects on aggressiveness and anxiety in OF1 male mice. Psychopharmacol 177 : 418 427.
55. Redolat R, Oterino MC, Carrasco MC, Berry MS, Brain PF (2000) Effects of acute administration of nicotine and lobeline on agonistic encounters in male mice. Aggress Behav 26 : 376 385.
56. Redolat R, Oterino MC, Carrasco MC, Brain PF (2002) A specific anti-aggressive effect of repeatedly administered lobeline. Addict Biol 7 : 301 306.
57. Redolat R, Vidal J, Gómez MC, Carrasco MC (2005b) Effects of acute bupropion administration on locomotor activity in adolescent and adult mice. Behav Pharmacol 16 : 59 62.
58. 3 antagonist U-99194A maleate increases social behaviors of isolation-induced aggressive male mice. Psychopharmacol 144 : 90 94.
59. Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C (2005) Naltrexone reduced the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacol 180 : 41 48.
60. Shiffman S, Johnston JA, Khayrallah Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J (2000) The effect of bupropion on nicotine craving and withdrawal. Psychopharmacol 148 : 33 40.
61. Sidhpura N, Redfern P, Rowley H, Heal D, Wonnacott S (2007) Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo. Biochem Pharmacol 15 : 1292 1298.
62. Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295 : 321 327.
63. Sluyter F, Korte SM, Bohus B, Van Oortmerssen GA (1996) Behavioral stress response of genetically selected aggressive and nonaggressive wild house mice in the shock-probe/defensive burying test. Pharmacol Biochem Behav 54 : 113 116.
64. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S (2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion. J Clin Psychiatry 6 : 159 166.
65. Taraschenko OD, Panchal V, Maisonneuve IM, Glick SD (2005) Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence? Eur J Pharmacol 513 : 207 218.
66. Vann RE, Rosecrans JA, James JR, Philibin SD, Robinson SE (2006) Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine. Brain Res 1117 : 18 24.
67. Vinader-Caerols C, Brain PF, Parra A, Simon VM (1992) An ethological analysis of the effects of diazepam and nitrazepam on the response of female mice to ansimic males encountered in a novel arena. Behav Pharmacol 3 : 427 433.
68. Ward MM, Swan GE, Jack LM (2001) Self-reported abstinence effects in the first month after smoking cessation. Addict Behav 26 : 311 327.
69. Warner C, Shoaib M (2005) How does bupropion work as a smoking cessation agent? Addict Biol 10 : 219 231.
70. West R, Shiffman S (2001) Effects of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacol 155 : 115 122.
71. Wing VC, Shoaib M (2007) Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. Psycopharmacol 195 : 303 313.